Evolution of anticancer drug discovery and the role of cell-based screening

被引：62

作者：

Balis, FM ^{[1
]}

机构：

[1] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2002年 / 94卷 / 02期

关键词：

D O I：

10.1093/jnci/94.2.78

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：78 / 79

页数：2

共 19 条

[1] Drug discovery: A historical perspective [J].

Drews, J .

SCIENCE, 2000, 287 (5460) :1960-1964

[2] Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome. [J].

Druker, BJ ;

Sawyers, CL ;

Kantarjian, H ;

Resta, DJ ;

Reese, SF ;

Ford, JM ;

Capdeville, R ;

Talpaz, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1038-1042

[3] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

[4] Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia [J].

Druker, BJ ;

Lydon, NB .

JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (01) :3-7

[5] Cell-based assays for identification of novel double-strand break-inducing agents [J].

Dunstan, HM ;

Ludlow, C ;

Goehle, S ;

Cronk, M ;

Szankasi, P ;

Evans, DRH ;

Simon, JR ;

Lamb, JR .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (02) :88-94

[6] Mechanism-based target identification and drug discovery in cancer research [J].

Gibbs, JB .

SCIENCE, 2000, 287 (5460) :1969-1973

[7] Anticancer drug targets: growth factors and growth factor signaling [J].

Gibbs, JB .

JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (01) :9-13

[8] Integrating genetic approaches into the discovery of anticancer drugs [J].

Hartwell, LH ;

Szankasi, P ;

Roberts, CJ ;

Murray, AW ;

Friend, SH .

SCIENCE, 1997, 278 (5340) :1064-1068

[9] Choosing anticancer drug targets in the postgenomic era [J].

Kaelin, WG .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (11) :1503-1506

[10] FEASIBILITY OF A HIGH-FLUX ANTICANCER DRUG SCREEN USING A DIVERSE PANEL OF CULTURED HUMAN TUMOR-CELL LINES [J].

MONKS, A ;

SCUDIERO, D ;

SKEHAN, P ;

SHOEMAKER, R ;

PAULL, K ;

VISTICA, D ;

HOSE, C ;

LANGLEY, J ;

CRONISE, P ;

VAIGROWOLFF, A ;

GRAYGOODRICH, M ;

CAMPBELL, H ;

MAYO, J ;

BOYD, M .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (11) :757-766

← 1 2 →